Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 75 entries
Sorted by: Best Match Show Resources per page
C-N Bond Formation from a Masked High-Valent Copper Complex Stabilized by Redox Non-Innocent Ligands.

Angewandte Chemie (International ed. in English)

Jacquet J, Chaumont P, Gontard G, Orio M, Vezin H, Blanchard S, Desage-El Murr M, Fensterbank L.
PMID: 27504607
Angew Chem Int Ed Engl. 2016 Aug 26;55(36):10712-6. doi: 10.1002/anie.201605132. Epub 2016 Aug 09.

The reactivity of a stable copper(II) complex bearing fully oxidized iminobenzoquinone redox ligands towards nucleophiles is described. In sharp contrast with its genuine low-valent counterpart bearing reduced ligands, this complex performs high-yielding C-N bond formations. Mechanistic studies suggest that...

Cite
Jacquet J, Chaumont P, Gontard G, et al. C-N Bond Formation from a Masked High-Valent Copper Complex Stabilized by Redox Non-Innocent Ligands. Angew Chem Int Ed Engl. 2016;55(36):10712-6doi: 10.1002/anie.201605132.
Jacquet, J., Chaumont, P., Gontard, G., Orio, M., Vezin, H., Blanchard, S., Desage-El Murr, M., & Fensterbank, L. (2016). C-N Bond Formation from a Masked High-Valent Copper Complex Stabilized by Redox Non-Innocent Ligands. Angewandte Chemie (International ed. in English), 55(36), 10712-6. https://doi.org/10.1002/anie.201605132
Jacquet, Jérémy, et al. "C-N Bond Formation from a Masked High-Valent Copper Complex Stabilized by Redox Non-Innocent Ligands." Angewandte Chemie (International ed. in English) vol. 55,36 (2016): 10712-6. doi: https://doi.org/10.1002/anie.201605132
Jacquet J, Chaumont P, Gontard G, Orio M, Vezin H, Blanchard S, Desage-El Murr M, Fensterbank L. C-N Bond Formation from a Masked High-Valent Copper Complex Stabilized by Redox Non-Innocent Ligands. Angew Chem Int Ed Engl. 2016 Aug 26;55(36):10712-6. doi: 10.1002/anie.201605132. Epub 2016 Aug 09. PMID: 27504607.
Copy Download .nbib Format: NLM
Series of Hydrated Heterometallic Uranyl-Cobalt(II) Coordination Polymers with Aromatic Polycarboxylate Ligands: Formation of U═O-Co Bonding upon Dehydration Process.

Inorganic chemistry

Falaise C, Delille J, Volkringer C, Vezin H, Rabu P, Loiseau T.
PMID: 27709964
Inorg Chem. 2016 Oct 17;55(20):10453-10466. doi: 10.1021/acs.inorgchem.6b01697. Epub 2016 Oct 06.

Five new heterometallic UO

Cite
Falaise C, Delille J, Volkringer C, et al. Series of Hydrated Heterometallic Uranyl-Cobalt(II) Coordination Polymers with Aromatic Polycarboxylate Ligands: Formation of U═O-Co Bonding upon Dehydration Process. Inorg Chem. 2016;55(20):10453-10466doi: 10.1021/acs.inorgchem.6b01697.
Falaise, C., Delille, J., Volkringer, C., Vezin, H., Rabu, P., & Loiseau, T. (2016). Series of Hydrated Heterometallic Uranyl-Cobalt(II) Coordination Polymers with Aromatic Polycarboxylate Ligands: Formation of U═O-Co Bonding upon Dehydration Process. Inorganic chemistry, 55(20), 10453-10466. https://doi.org/10.1021/acs.inorgchem.6b01697
Falaise, Clément, et al. "Series of Hydrated Heterometallic Uranyl-Cobalt(II) Coordination Polymers with Aromatic Polycarboxylate Ligands: Formation of U═O-Co Bonding upon Dehydration Process." Inorganic chemistry vol. 55,20 (2016): 10453-10466. doi: https://doi.org/10.1021/acs.inorgchem.6b01697
Falaise C, Delille J, Volkringer C, Vezin H, Rabu P, Loiseau T. Series of Hydrated Heterometallic Uranyl-Cobalt(II) Coordination Polymers with Aromatic Polycarboxylate Ligands: Formation of U═O-Co Bonding upon Dehydration Process. Inorg Chem. 2016 Oct 17;55(20):10453-10466. doi: 10.1021/acs.inorgchem.6b01697. Epub 2016 Oct 06. PMID: 27709964.
Copy Download .nbib Format: NLM
Electron paramagnetic resonance imaging for real-time monitoring of Li-ion batteries.

Nature communications

Sathiya M, Leriche JB, Salager E, Gourier D, Tarascon JM, Vezin H.
PMID: 25662295
Nat Commun. 2015 Feb 09;6:6276. doi: 10.1038/ncomms7276.

Batteries for electrical storage are central to any future alternative energy paradigm. The ability to probe the redox mechanisms occurring at electrodes during their operation is essential to improve battery performances. Here we present the first report on Electron...

Cite
Sathiya M, Leriche JB, Salager E, et al. Electron paramagnetic resonance imaging for real-time monitoring of Li-ion batteries. Nat Commun. 2015;6:6276doi: 10.1038/ncomms7276.
Sathiya, M., Leriche, J. B., Salager, E., Gourier, D., Tarascon, J. M., & Vezin, H. (2015). Electron paramagnetic resonance imaging for real-time monitoring of Li-ion batteries. Nature communications, 66276. https://doi.org/10.1038/ncomms7276
Sathiya, M, et al. "Electron paramagnetic resonance imaging for real-time monitoring of Li-ion batteries." Nature communications vol. 6 (2015): 6276. doi: https://doi.org/10.1038/ncomms7276
Sathiya M, Leriche JB, Salager E, Gourier D, Tarascon JM, Vezin H. Electron paramagnetic resonance imaging for real-time monitoring of Li-ion batteries. Nat Commun. 2015 Feb 09;6:6276. doi: 10.1038/ncomms7276. PMID: 25662295; PMCID: PMC4347297.
Copy Download .nbib Format: NLM
Sarcoptic mange and other ectoparasitic infections in a red fox (.

Parasite epidemiology and control

Perrucci S, Verin R, Mancianti F, Poli A.
PMID: 29988193
Parasite Epidemiol Control. 2016 Mar 30;1(2):66-71. doi: 10.1016/j.parepi.2016.03.007. eCollection 2016 Jun.

Fifty red foxes (

Cite
Perrucci S, Verin R, Mancianti F, et al. Sarcoptic mange and other ectoparasitic infections in a red fox (. Parasite Epidemiol Control. 2016;1(2):66-71doi: 10.1016/j.parepi.2016.03.007.
Perrucci, S., Verin, R., Mancianti, F., & Poli, A. (2016). Sarcoptic mange and other ectoparasitic infections in a red fox (. Parasite epidemiology and control, 1(2), 66-71. https://doi.org/10.1016/j.parepi.2016.03.007
Perrucci, S, et al. "Sarcoptic mange and other ectoparasitic infections in a red fox (." Parasite epidemiology and control vol. 1,2 (2016): 66-71. doi: https://doi.org/10.1016/j.parepi.2016.03.007
Perrucci S, Verin R, Mancianti F, Poli A. Sarcoptic mange and other ectoparasitic infections in a red fox (. Parasite Epidemiol Control. 2016 Mar 30;1(2):66-71. doi: 10.1016/j.parepi.2016.03.007. eCollection 2016 Jun. PMID: 29988193; PMCID: PMC5991845.
Copy Download .nbib Format: NLM
Pathology of Coronavirus Infections: A Review of Lesions in Animals in the One-Health Perspective.

Animals : an open access journal from MDPI

Zappulli V, Ferro S, Bonsembiante F, Brocca G, Calore A, Cavicchioli L, Centelleghe C, Corazzola G, De Vreese S, Gelain ME, Mazzariol S, Moccia V, Rensi N, Sammarco A, Torrigiani F, Verin R, Castagnaro M.
PMID: 33322366
Animals (Basel). 2020 Dec 11;10(12). doi: 10.3390/ani10122377.

Coronaviruses (CoVs) are worldwide distributed RNA-viruses affecting several species, including humans, and causing a broad spectrum of diseases. Historically, they have not been considered a severe threat to public health until two outbreaks of COVs-related atypical human pneumonia derived...

Cite
Zappulli V, Ferro S, Bonsembiante F, et al. Pathology of Coronavirus Infections: A Review of Lesions in Animals in the One-Health Perspective. Animals (Basel). 2020;10(12)doi: 10.3390/ani10122377.
Zappulli, V., Ferro, S., Bonsembiante, F., Brocca, G., Calore, A., Cavicchioli, L., Centelleghe, C., Corazzola, G., De Vreese, S., Gelain, M. E., Mazzariol, S., Moccia, V., Rensi, N., Sammarco, A., Torrigiani, F., Verin, R., & Castagnaro, M. (2020). Pathology of Coronavirus Infections: A Review of Lesions in Animals in the One-Health Perspective. Animals : an open access journal from MDPI, 10(12), . https://doi.org/10.3390/ani10122377
Zappulli, Valentina, et al. "Pathology of Coronavirus Infections: A Review of Lesions in Animals in the One-Health Perspective." Animals : an open access journal from MDPI vol. 10,12 (2020). doi: https://doi.org/10.3390/ani10122377
Zappulli V, Ferro S, Bonsembiante F, Brocca G, Calore A, Cavicchioli L, Centelleghe C, Corazzola G, De Vreese S, Gelain ME, Mazzariol S, Moccia V, Rensi N, Sammarco A, Torrigiani F, Verin R, Castagnaro M. Pathology of Coronavirus Infections: A Review of Lesions in Animals in the One-Health Perspective. Animals (Basel). 2020 Dec 11;10(12). doi: 10.3390/ani10122377. PMID: 33322366; PMCID: PMC7764021.
Copy Download .nbib Format: NLM
Coronary sinus to left atrium fistula on computed tomography angiography: Differentiation from unroofed coronary sinus with literature review.

Journal of cardiovascular computed tomography

Abazid RM, Goha A, Romsa JG, Warrington JC, Akincioglu C, Stodilka RZ, Kiaii B, Vezina WC.
PMID: 33229304
J Cardiovasc Comput Tomogr. 2021 Mar-Apr;15(2):e15-e17. doi: 10.1016/j.jcct.2020.11.003. Epub 2020 Nov 13.

No abstract available.

Cite
Abazid RM, Goha A, Romsa JG, et al. Coronary sinus to left atrium fistula on computed tomography angiography: Differentiation from unroofed coronary sinus with literature review. J Cardiovasc Comput Tomogr. 2020;15(2):e15-e17doi: 10.1016/j.jcct.2020.11.003.
Abazid, R. M., Goha, A., Romsa, J. G., Warrington, J. C., Akincioglu, C., Stodilka, R. Z., Kiaii, B., & Vezina, W. C. (2021). Coronary sinus to left atrium fistula on computed tomography angiography: Differentiation from unroofed coronary sinus with literature review. Journal of cardiovascular computed tomography, 15(2), e15-e17. https://doi.org/10.1016/j.jcct.2020.11.003
Abazid, Rami M, et al. "Coronary sinus to left atrium fistula on computed tomography angiography: Differentiation from unroofed coronary sinus with literature review." Journal of cardiovascular computed tomography vol. 15,2 (2021): e15-e17. doi: https://doi.org/10.1016/j.jcct.2020.11.003
Abazid RM, Goha A, Romsa JG, Warrington JC, Akincioglu C, Stodilka RZ, Kiaii B, Vezina WC. Coronary sinus to left atrium fistula on computed tomography angiography: Differentiation from unroofed coronary sinus with literature review. J Cardiovasc Comput Tomogr. 2021 Mar-Apr;15(2):e15-e17. doi: 10.1016/j.jcct.2020.11.003. Epub 2020 Nov 13. PMID: 33229304.
Copy Download .nbib Format: NLM
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.

The Lancet. Oncology

Jacobson CA, Chavez JC, Sehgal AR, William BM, Munoz J, Salles G, Munshi PN, Casulo C, Maloney DG, de Vos S, Reshef R, Leslie LA, Yakoub-Agha I, Oluwole OO, Fung HCH, Rosenblatt J, Rossi JM, Goyal L, Plaks V, Yang Y, Vezan R, Avanzi MP, Neelapu SS.
PMID: 34895487
Lancet Oncol. 2022 Jan;23(1):91-103. doi: 10.1016/S1470-2045(21)00591-X. Epub 2021 Dec 08.

BACKGROUND: Most patients with advanced-stage indolent non-Hodgkin lymphoma have multiple relapses. We assessed axicabtagene ciloleucel autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in relapsed or refractory indolent non-Hodgkin lymphoma.METHODS: ZUMA-5 is a single-arm, multicentre, phase 2 trial being...

Cite
Jacobson CA, Chavez JC, Sehgal AR, et al. Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial. Lancet Oncol. 2021;23(1):91-103doi: 10.1016/S1470-2045(21)00591-X.
Jacobson, C. A., Chavez, J. C., Sehgal, A. R., William, B. M., Munoz, J., Salles, G., Munshi, P. N., Casulo, C., Maloney, D. G., de Vos, S., Reshef, R., Leslie, L. A., Yakoub-Agha, I., Oluwole, O. O., Fung, H. C. H., Rosenblatt, J., Rossi, J. M., Goyal, L., Plaks, V., Yang, Y., Vezan, R., Avanzi, M. P., & Neelapu, S. S. (2022). Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial. The Lancet. Oncology, 23(1), 91-103. https://doi.org/10.1016/S1470-2045(21)00591-X
Jacobson, Caron A, et al. "Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial." The Lancet. Oncology vol. 23,1 (2022): 91-103. doi: https://doi.org/10.1016/S1470-2045(21)00591-X
Jacobson CA, Chavez JC, Sehgal AR, William BM, Munoz J, Salles G, Munshi PN, Casulo C, Maloney DG, de Vos S, Reshef R, Leslie LA, Yakoub-Agha I, Oluwole OO, Fung HCH, Rosenblatt J, Rossi JM, Goyal L, Plaks V, Yang Y, Vezan R, Avanzi MP, Neelapu SS. Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial. Lancet Oncol. 2022 Jan;23(1):91-103. doi: 10.1016/S1470-2045(21)00591-X. Epub 2021 Dec 08. PMID: 34895487.
Copy Download .nbib Format: NLM
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.

The Lancet. Oncology

Jacobson CA, Chavez JC, Sehgal AR, William BM, Munoz J, Salles G, Munshi PN, Casulo C, Maloney DG, de Vos S, Reshef R, Leslie LA, Yakoub-Agha I, Oluwole OO, Fung HCH, Rosenblatt J, Rossi JM, Goyal L, Plaks V, Yang Y, Vezan R, Avanzi MP, Neelapu SS.
PMID: 34895487
Lancet Oncol. 2021 Dec 08; doi: 10.1016/S1470-2045(21)00591-X. Epub 2021 Dec 08.

BACKGROUND: Most patients with advanced-stage indolent non-Hodgkin lymphoma have multiple relapses. We assessed axicabtagene ciloleucel autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in relapsed or refractory indolent non-Hodgkin lymphoma.METHODS: ZUMA-5 is a single-arm, multicentre, phase 2 trial being...

Cite
Jacobson CA, Chavez JC, Sehgal AR, et al. Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial. Lancet Oncol. 2021;doi: 10.1016/S1470-2045(21)00591-X.
Jacobson, C. A., Chavez, J. C., Sehgal, A. R., William, B. M., Munoz, J., Salles, G., Munshi, P. N., Casulo, C., Maloney, D. G., de Vos, S., Reshef, R., Leslie, L. A., Yakoub-Agha, I., Oluwole, O. O., Fung, H. C. H., Rosenblatt, J., Rossi, J. M., Goyal, L., Plaks, V., Yang, Y., Vezan, R., Avanzi, M. P., & Neelapu, S. S. (2021). Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial. The Lancet. Oncology, . https://doi.org/10.1016/S1470-2045(21)00591-X
Jacobson, Caron A, et al. "Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial." The Lancet. Oncology vol. (2021). doi: https://doi.org/10.1016/S1470-2045(21)00591-X
Jacobson CA, Chavez JC, Sehgal AR, William BM, Munoz J, Salles G, Munshi PN, Casulo C, Maloney DG, de Vos S, Reshef R, Leslie LA, Yakoub-Agha I, Oluwole OO, Fung HCH, Rosenblatt J, Rossi JM, Goyal L, Plaks V, Yang Y, Vezan R, Avanzi MP, Neelapu SS. Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial. Lancet Oncol. 2021 Dec 08; doi: 10.1016/S1470-2045(21)00591-X. Epub 2021 Dec 08. PMID: 34895487.
Copy Download .nbib Format: NLM
Tc-99m pyrophosphate left atrial uptake in patients with atrial fibrillation and cardiac amyloidosis.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology

Abazid RM, Romsa JG, Warrington JC, Stodilka RZ, Davey RA, De S, Laidley DL, Vezina WC, Akincioglu C.
PMID: 33502692
J Nucl Cardiol. 2021 Jan 27; doi: 10.1007/s12350-020-02508-3. Epub 2021 Jan 27.

No abstract available.

Cite
Abazid RM, Romsa JG, Warrington JC, et al. Tc-99m pyrophosphate left atrial uptake in patients with atrial fibrillation and cardiac amyloidosis. J Nucl Cardiol. 2021;doi: 10.1007/s12350-020-02508-3.
Abazid, R. M., Romsa, J. G., Warrington, J. C., Stodilka, R. Z., Davey, R. A., De, S., Laidley, D. L., Vezina, W. C., & Akincioglu, C. (2021). Tc-99m pyrophosphate left atrial uptake in patients with atrial fibrillation and cardiac amyloidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, . https://doi.org/10.1007/s12350-020-02508-3
Abazid, Rami M, et al. "Tc-99m pyrophosphate left atrial uptake in patients with atrial fibrillation and cardiac amyloidosis." Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology vol. (2021). doi: https://doi.org/10.1007/s12350-020-02508-3
Abazid RM, Romsa JG, Warrington JC, Stodilka RZ, Davey RA, De S, Laidley DL, Vezina WC, Akincioglu C. Tc-99m pyrophosphate left atrial uptake in patients with atrial fibrillation and cardiac amyloidosis. J Nucl Cardiol. 2021 Jan 27; doi: 10.1007/s12350-020-02508-3. Epub 2021 Jan 27. PMID: 33502692.
Copy Download .nbib Format: NLM
Correction: EPR imaging of sinapyl alcohol and its application to the study of plant cell wall lignification.

Chemical communications (Cambridge, England)

Simon C, Lion C, Ahouari H, Vezin H, Hawkins S, Biot C.
PMID: 33393953
Chem Commun (Camb). 2021 Jan 11;57(3):404. doi: 10.1039/d0cc90541k. Epub 2021 Jan 04.

Correction for 'EPR imaging of sinapyl alcohol and its application to the study of plant cell wall lignification' by Clémence Simon et al., Chem. Commun., 2021, DOI: .

Cite
Simon C, Lion C, Ahouari H, et al. Correction: EPR imaging of sinapyl alcohol and its application to the study of plant cell wall lignification. Chem Commun (Camb). 2021;57(3):404doi: 10.1039/d0cc90541k.
Simon, C., Lion, C., Ahouari, H., Vezin, H., Hawkins, S., & Biot, C. (2021). Correction: EPR imaging of sinapyl alcohol and its application to the study of plant cell wall lignification. Chemical communications (Cambridge, England), 57(3), 404. https://doi.org/10.1039/d0cc90541k
Simon, Clémence, et al. "Correction: EPR imaging of sinapyl alcohol and its application to the study of plant cell wall lignification." Chemical communications (Cambridge, England) vol. 57,3 (2021): 404. doi: https://doi.org/10.1039/d0cc90541k
Simon C, Lion C, Ahouari H, Vezin H, Hawkins S, Biot C. Correction: EPR imaging of sinapyl alcohol and its application to the study of plant cell wall lignification. Chem Commun (Camb). 2021 Jan 11;57(3):404. doi: 10.1039/d0cc90541k. Epub 2021 Jan 04. PMID: 33393953.
Copy Download .nbib Format: NLM
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial.

The Lancet. Oncology

Jacobson CA, Chavez JC, Sehgal AR, William BM, Munoz J, Salles G, Munshi PN, Casulo C, Maloney DG, de Vos S, Reshef R, Leslie LA, Yakoub-Agha I, Oluwole OO, Fung HCH, Rosenblatt J, Rossi JM, Goyal L, Plaks V, Yang Y, Vezan R, Avanzi MP, Neelapu SS.
PMID: 34895487
Lancet Oncol. 2022 Jan;23(1):91-103. doi: 10.1016/S1470-2045(21)00591-X. Epub 2021 Dec 08.

BACKGROUND: Most patients with advanced-stage indolent non-Hodgkin lymphoma have multiple relapses. We assessed axicabtagene ciloleucel autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in relapsed or refractory indolent non-Hodgkin lymphoma.METHODS: ZUMA-5 is a single-arm, multicentre, phase 2 trial being...

Cite
Jacobson CA, Chavez JC, Sehgal AR, et al. Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial. Lancet Oncol. 2021;23(1):91-103doi: 10.1016/S1470-2045(21)00591-X.
Jacobson, C. A., Chavez, J. C., Sehgal, A. R., William, B. M., Munoz, J., Salles, G., Munshi, P. N., Casulo, C., Maloney, D. G., de Vos, S., Reshef, R., Leslie, L. A., Yakoub-Agha, I., Oluwole, O. O., Fung, H. C. H., Rosenblatt, J., Rossi, J. M., Goyal, L., Plaks, V., Yang, Y., Vezan, R., Avanzi, M. P., & Neelapu, S. S. (2022). Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial. The Lancet. Oncology, 23(1), 91-103. https://doi.org/10.1016/S1470-2045(21)00591-X
Jacobson, Caron A, et al. "Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial." The Lancet. Oncology vol. 23,1 (2022): 91-103. doi: https://doi.org/10.1016/S1470-2045(21)00591-X
Jacobson CA, Chavez JC, Sehgal AR, William BM, Munoz J, Salles G, Munshi PN, Casulo C, Maloney DG, de Vos S, Reshef R, Leslie LA, Yakoub-Agha I, Oluwole OO, Fung HCH, Rosenblatt J, Rossi JM, Goyal L, Plaks V, Yang Y, Vezan R, Avanzi MP, Neelapu SS. Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial. Lancet Oncol. 2022 Jan;23(1):91-103. doi: 10.1016/S1470-2045(21)00591-X. Epub 2021 Dec 08. PMID: 34895487.
Copy Download .nbib Format: NLM
Gammaherpesvirus Infections in Cattle in Europe.

Viruses

Rosato G, Ruiz Subira A, Al-Saadi M, Michalopoulou E, Verin R, Dettwiler M, Nordgren H, Chiers K, Groβmann E, Köhler K, Suntz M, Stewart JP, Kipar A.
PMID: 34960607
Viruses. 2021 Nov 23;13(12). doi: 10.3390/v13122337.

The genus Macavirus, subfamily Gammaherpesvirinae, comprises ungulate viruses that infect domestic and wild ruminants and swine. They cause asymptomatic latent infections in reservoir hosts and malignant catarrhal fever in susceptible species. Lung, spleen, bronchial lymph node, and tongue were...

Cite
Rosato G, Ruiz Subira A, Al-Saadi M, et al. Gammaherpesvirus Infections in Cattle in Europe. Viruses. 2021;13(12)doi: 10.3390/v13122337.
Rosato, G., Ruiz Subira, A., Al-Saadi, M., Michalopoulou, E., Verin, R., Dettwiler, M., Nordgren, H., Chiers, K., Groβmann, E., Köhler, K., Suntz, M., Stewart, J. P., & Kipar, A. (2021). Gammaherpesvirus Infections in Cattle in Europe. Viruses, 13(12), . https://doi.org/10.3390/v13122337
Rosato, Giuliana, et al. "Gammaherpesvirus Infections in Cattle in Europe." Viruses vol. 13,12 (2021). doi: https://doi.org/10.3390/v13122337
Rosato G, Ruiz Subira A, Al-Saadi M, Michalopoulou E, Verin R, Dettwiler M, Nordgren H, Chiers K, Groβmann E, Köhler K, Suntz M, Stewart JP, Kipar A. Gammaherpesvirus Infections in Cattle in Europe. Viruses. 2021 Nov 23;13(12). doi: 10.3390/v13122337. PMID: 34960607.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 75 entries